FireGate Biotech is an independent biotechnology company developing next-generation immunotherapies centered on CCR5 blockade, PD-L1 modulation, and broadly neutralizing antibodies (bNAbs). Our mission is to advance scalable, translational platforms that enable functional HIV remission, novel oncology applications, and neuro-immune restoration in inflammatory and demyelinating disease, uniting rigorous science, clinical practicality, and responsible innovation. Learn more at FireGateBiotech.com
| Website | https://firegatebiotech.com |
| Employees | 3 (2 on RocketReach) |
| Founded | 2025 |
| Address | 1930 18th St NW B2 PMB2161, Washington, District of Columbia 20005, US |
| Industry | Biotechnology Research |
Looking for a particular FireGate Biotech employee's phone or email?
FireGate Biotech Questions
Daniel Rizzo is the CEO of FireGate Biotech.
2 people are employed at FireGate Biotech.
FireGate Biotech is based in Washington, District of Columbia.
Top FireGate Biotech Employees
-
Daniel Rizzo
Chief Executive Officer at FireGate Biotech
United States1 -
Andrzej Gajewski
Scientific Adviser 2026 - Present Scientific Advisor, at FireGate Biotech
West Palm Beach, FL, US25
